Non-invasive Prenatal MT-RNR1 Pharmacogenetic Testing for the Prevention of Aminoglycoside-Induced Profound Hearing Loss
Aspasia Destouni, Benelote Uusküla, Javier Lanillos, Hindrek Teder et autres
2 citationsmedRxiv
Javier Lanillos
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
25Publications signalées
455Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Renal cell carcinoma treatmentCancer Genomics and DiagnosticsRenal and related cancersPI3K/AKT/mTOR signaling in cancerUbiquitin and proteasome pathways
Publications récentes
Identification of a novel papillary renal cell carcinoma molecular subtype characterized by HIF-pathway over-activation
Javier de Nicolás‐Hernández, Alicia Arenas, Carlos Valdivia, María Santos et autres
1 citationbioRxiv (Cold Spring Harbor Laboratory)
Deubiquitinase USP9X loss sensitizes renal cancer cells to mTOR inhibition
Juan María Roldán‐Romero, Carlos Valdivia, María Santos, Javier Lanillos et autres
18 citationsInternational Journal of Cancer
DLST mutations in pheochromocytoma and paraganglioma cause proteome hyposuccinylation and metabolic remodeling
Sara Mellid, Fernando Garcı́a, Luis J. Leandro‐García, Alberto Díaz‐Talavera et autres
10 citations癌症：英文版
Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma
Bruna Calsina, Elena Piñeiro-Yáñez, Ángel M. Martínez‐Montes, Eduardo Caleiras et autres
105 citationsNature Communications
PBRM1 and KDM5C cooperate to define high-angiogenesis tumors and increased antiangiogenic response in renal cancer.
María Santos, Javier Lanillos, Eduardo Caleiras, Carlos E. Valdivia et autres
5 citationsPubMed
Interrogating the Significance of PARP1 Expression and PBRM1 Mutation as Biomarkers for Predicting the Response to Atezolizumab plus Bevacizumab or to Sunitinib in Patients with Clear Cell Renal Cell Carcinoma
Javier Lanillos, María Santos, Carlos E. Valdivia, Alberto Mora et autres
3 citationsEuropean Urology
Considerations on diagnosis and surveillance measures of PTEN hamartoma tumor syndrome: clinical and genetic study in a series of Spanish patients
Laura Pena-Couso, María Ercibengoa, Fátima Mercadillo, David Gómez-Sánchez et autres
8 citationsOrphanet Journal of Rare Diseases
Clinical pharmacogenetic analysis in 5,001 individuals with diagnostic Exome Sequencing data
Javier Lanillos, Marta Carcajona, Paolo Maietta, Sara Álvarez et autres
27 citationsnpj Genomic Medicine
Deubiquitinase USP9X loss Sensitizes Cancer Cells to mTOR Inhibitors through p62 Dysregulation
Juan María Roldán‐Romero, María Santos, Javier Lanillos, Pablo Maroto et autres
0 citationsResearch Square
Considerations on Diagnosis and Surveillance Measures of PTEN Hamartoma Tumor Syndrome: Clinical and Genetic Study in a Series of Spanish Patients.
Laura Pena-Couso, María Ercibengoa, Fátima Mercadillo, David Gómez-Sánchez et autres
1 citationResearch Square
Sunitinib and Evofosfamide ( TH -302) in Systemic Treatment-Naïve Patients with Grade 1/2 Metastatic Pancreatic Neuroendocrine Tumors: The GETNE -1408 Trial
Enrique Grande, Cristina Rodríguez‐Antona, Carlos López, Teresa Alonso‐Gordoa et autres
22 citationsThe Oncologist
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.